-
Breast Cancer: Making Treatment Decisions
With additional treatment options and an emphasis on reducing side effects, patients with breast cancer have more decisions to make than ever before.
by Natalie Slivinski
-
Survivor Profile
From Fear to ActionMike Herman hasn’t let a multiple myeloma diagnosis stop him from advocating for himself and teaching others to do the same.
by Suzanne McBride
-
The Push for Inclusive Cancer Care
People with intellectual or developmental disabilities face obstacles to receiving appropriate cancer screening and treatment. Advocates are calling on the health care system to meet their needs and increase access to care.
by Thomas Celona
-
Get Involved
Happy FeetThe HallieStrong Foundation sends people receiving cancer treatment socks designed to put smiles on their faces.
by Thomas Celona
-
Facts and Stats
Treatment Advances Help Fuel Survival IncreasesPeople with localized esophageal cancer and advanced melanoma have benefited from improved cancer care.
by Thomas Celona
-
Making Cancer a Family Affair
Instead of hiding details of her metastatic breast cancer diagnosis from her children, Michelle Audoin opened the door for clear expectations and frank conversations.
by Michelle Audoin
-
Advocacy After Loss
Following her son’s death from peripheral T-cell lymphoma, Sandy McHugh keeps his memory alive through Jake’s Dragon Foundation.
by Thomas Celona
-
Telehealth Palliative Care Provides the Same Benefits as In-person Care
Researchers hope effective telehealth will increase access to palliative care for more cancer patients.
by Taneia Surles
-
Living With Your Loved One’s Prostate Cancer
Christine Ledbetter on the ways her husband’s prostate cancer affected their relationship and finding support as a caregiver.
by Christine Ledbetter
-
Immunotherapy Drug Tarlatamab Approved for Advanced Small Cell Lung Cancer
The drug showed promise in treating small cell lung cancer that had progressed during or after chemotherapy.
by Laura Gesualdi-Gilmore
Cancer Talk
Treating Smoldering Multiple Myeloma
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona